Arcutis Biotherapeutics Inc

ARQTNASDAQ · USD
26.36USD0.00 (-2.99%)
319

Arcutis Biotherapeutics Inc (ARQT) Option Chain

Read more

Tracking the ARQT option chain helps you see every strike and expiry on Arcutis Biotherapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ARQT options activity at a glance. Use our scanner to monitor the ARQT option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ARQT stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ARQT options are being actively traded, and where they are not.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata.

2026-12-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
22.55200.893.862.507.0022.50-14.64—2.550.002.5501477.45
42.08901.371.360.554.9025.00-5.16—4.900.004.9003057.92
61.832104.600.00—4.6027.50+4.320.304.901.141.4602338.17
77.5930752.600.000.205.0030.00+13.811.506.003.640.1101122.41
88.092201.500.00—1.5032.50+23.294.107.706.14-0.240411.91

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank43.65% Moderate
  • Market cap (M$)3,333
  • 52 weeks high-24.25%
  • 52 weeks low36.58%
  • Analyst recommendationStrong Buy
    1.25
  • Target price$40.38
    53.19% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E122.21
  • Future P/E25.13
  • EPS (ttm)0.22
  • EPS growth next 5 years—

As of Nov 20, 2026